The online GLP-1 market is changing quickly. Oral medicines are opening up a new route for people who are reluctant to use injections. In the UK, oral Wegovy was approved in June 2026, followed by Lilly’s oral orforglipron in August. Tablets may be easier to distribute than injectable medicines, which can require cold-chain handling. But approval doesn’t automatically mean broad availability, NHS access or lower prices.
New versions create more customer acquisition avenues
At the same time, older treatments are beginning to face generic competition. Liraglutide, the active ingredient in Saxenda, is one example . As more generic options become available through online pharmacy services, patients may have greater choice, though a prescription and appropriate clinical oversight remain essential. Lower manufacturing or distribution costs also don’t guarantee a lower price for patients. Asda and Super Drug online pharmacies are selling generics for 33% less than the branded version and list the branded version as “out of stock”. A cunning way to lure traffic in on brand then sell the generic Nevolat.
The opportunity for independent pharmacies
For independent pharmacies, this could be more than a passing trend. Weight-management services may create ongoing relationships and recurring monthly revenues, rather like dog food subscriptions do for the pet industry. Pharmacies with prescribing capability, or a partnership with a prescribing pharmacist or GP, could be well placed to serve local demand. The opportunity is to build a trustworthy, clinically responsible service around patients’ needs, not simply to sell a product.
The challenge for Independent Pharmacies accessing the online market place for new customers
In our experience of dealing with medical accounts, both in the UK and US, the digital side is often where a promising opportunity becomes difficult to deliver. We’ve won awards in healthcare marketing and worked on some of the most challenging accounts in the sector – find out more about our experience in the sector.
We’ve seen how off-the-shelf pharmacy websites can fall short and many local pharmacies have complained that online advertising doesn’t work for them, here’s why:
- The language on the site doesn’t match what consumers re searching for. Industry terminology can be unfamiliar to patients, making it harder for pharmacies to reach them digitally.
- Tracking on most websites is basic and does not pass sales back to the paid source i.e. Google, making it difficult to optimise for more customers. You need to be able to follow the entire customer journey.
- Essential features may carry extra fees which are variable, making it difficult for the pharmacy to control costs and nurture the enquiry properly to the final sale.
- Medicines and healthcare services advertising are subject to strict rules, and Google’s policies can restrict what advertisers may promote and how. A standard agency approach can create compliance risks, including account suspensions, which can be indefinite.
The solutions for Pharmacies to crack the online opportunity?
Independent pharmacies need a clear digital strategy: one that uses patient-friendly language, measures performance properly and treats regulatory requirements as a core part of the work. That’s how pharmacies can pursue the GLP-1 opportunity sustainably, not just get online, but build a service patients can find and trust, whilst banking a monthly recurring revenue.
If digital marketing hasn’t met your expectations, or if you’re about to embark on an online journey and you’d like to discuss the pitfalls to avoid, please book in for a strategic review.
